期刊
JOURNAL OF NEUROCHEMISTRY
卷 130, 期 6, 页码 780-789出版社
WILEY-BLACKWELL
DOI: 10.1111/jnc.12771
关键词
aging; anxiety; astrocyte; GABAergic neuron; quetiapine
资金
- Manitoba Health Research Council Foundation
- Canadian Institutes of Health Research Foundation
- Winnipeg Health Science Centre Foundation
- AstraZeneca Canada, Inc
- Pfizer Canada, Inc.
Previous studies have demonstrated that quetiapine (QTP) may have neuroprotective properties; however, the underlying mechanisms have not been fully elucidated. In this study, we identified a novel mechanism by which QTP increased the synthesis of ATP in astrocytes and protected GABAergic neurons from aging-induced death. In 12-month-old mice, QTP significantly improved cell number of GABAegic neurons in the cortex and ameliorated anxiety-like behaviors compared to control group. Complimentary in vitro studies showed that QTP had no direct effect on the survival of aging GABAergic neurons in culture. Astrocyte-conditioned medium (ACM) pretreated with QTP (ACM(QTP)) for 24h effectively protected GABAergic neurons against aging-induced spontaneous cell death. It was also found that QTP boosted the synthesis of ATP from cultured astrocytes after 24h of treatment, which might be responsible for the protective effects on neurons. Consistent with the above findings, a Rhodamine 123 test showed that ACM(QTP), not QTP itself, was able to prevent the decrease in mitochondrial membrane potential in the aging neurons. For the first time, our study has provided evidence that astrocytes may be the conduit through which QTP is able to exert its neuroprotective effects on GABAergic neurons.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据